Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | CASP3 | P42574 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.35 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.35 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | RARG | P13631 | 1/20 | 0.32 |
| ▸ | RXRA | P19793 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3538164 | 0.85 | PTGS2 (0.31) | PTGS2RARGRXRAPPARG | |
| SCHEMBL3531495 | 0.85 | — | — | |
| SCHEMBL3537498 | 0.84 | HTT (0.40) | NPC1RAB9APTGS2RARGRXRA | |
| SCHEMBL12199846 | 0.82 | NR1I2 (0.34) | MEN1NPC1RAB9AKMT2A | |
| SCHEMBL14594263 | 0.81 | NR1I2 (0.31) | — | |
| SCHEMBL3538222 | 0.80 | HSP90AA1 (0.38) | NPC1RAB9A | |
| SCHEMBL13017779 | 0.79 | ADORA2A (0.33) | MEN1NPC1RAB9AKMT2APTGS2 | |
| SCHEMBL12706079 | 0.77 | SMN1; SMN2 (0.37) | MEN1NPC1RAB9AKMT2A | |
| SCHEMBL3534901 | 0.74 | DHFR (0.30) | — | |
| SCHEMBL3770921 | 0.73 | CA2 (0.42) | PTGS2RARGRXRAPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060083945-A1 | New luminescent compositions and their uses | HITACHI CHEMICAL CO. LTD. (JP) | 2006-04-20 | — | — | US | claimed |
| WO-2006041221-A1 | NEW LUMINESCENT COMPOSITIONS AND THEIR USES | HITACHI CHEMICAL CO., LTD. (JP) | 2006-04-20 | — | — | WO | claimed |
| US-7714099-B2 | Luminescent compositions and their uses | HITACHI CHEMICAL CO., LTD. (JP) | 2010-05-11 | — | — | US | disclosed |
| US-20060083945-A1 | New luminescent compositions and their uses | HITACHI CHEMICAL CO. LTD. (JP) | 2006-04-20 | — | — | US | disclosed |
| WO-2006041221-A1 | NEW LUMINESCENT COMPOSITIONS AND THEIR USES | HITACHI CHEMICAL CO., LTD. (JP) | 2006-04-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060083945-A1 | New luminescent compositions and their uses | OCIAD1, NLRP3, OCIAD2 | MEN1 4288/4885NPC1 4245/4885CASP3 2153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.